Delivery Order SPE2DX15D6028-B456
- Not listed
- This federal contract award, with ID SPE2DX15D6028|SPE2DX23FWPGH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.27 firm fixed-price delivery order is for 4560685763 CELECOXIB 200MG 500S, a pharmaceutical product. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,050.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Celecoxib 200mg medication, a non-set-aside requirement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award, with ID SPE2DX15D6028|B392, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $101,540.05 firm fixed-price delivery order is for the supply of Celebrex 200mg medication. No set-aside was used for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQEVU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,434.56 firm fixed-price delivery order is for the supply of 4568142809 Celecoxib 200 mg capsules, and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,197.61, is for the delivery of 4,562,868,648 capsules of the medication Celecoxib 200 mg. This is a firm fixed-price delivery order contract with an ultimate completion date of November 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, identified as SPE2DX15D6028|K445, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $150,011.43 firm fixed-price delivery order is for the supply of CELEBREX 200MG 100S medication, with a completion date of January 5, 2017. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsule in unit dose packaging (100 count) under a firm fixed-price contract valued at $4,985.13. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency Troop Support Medical awarded a $561 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 count bottles of the prescription drug Celecoxib. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information. The Defense...
- This federal contract award, with ID SPE2DX15D7053|SPE2DX22FHC04, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $1,372.95 firm fixed-price delivery order is for the supply of pharmaceutical products and medical supplies to support military treatment facilities and government healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds a significant indefinite delivery...
- This federal contract award, with ID SPE2DX22D0010|SPE2D824FMW32, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $176,852.53 firm fixed-price delivery order contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to...
- SPE2DX15D6028Indefinite Delivery Contract
- SPE2DX15D6028-B456Delivery Order
This federal contract award with ID SPE2DX15D6028|B456 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $303,759.00 firm-fixed-price delivery order is for the medical supply Celecoxib 200mg, a pharmaceutical product. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the Department of Justice Federal Bureau of Investigation through a separate IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $303.8k | 9/11/15 |